Valarhash, a leader in digital asset services, officially launches a new series of cryptocurrency miner hosting services, now enabling customers with remote online access to the operations of their mining machines. Registered users will have many features such as selecting their mining pool, withdrawing options and even re-selling their mining machine on the platform. Customers can purchase machines from Valarhash or other providers and have them shipped to the Valarhash mining farms. Valarhash is launching the new service series following an earlier announcement launching miner machine hosting plans. With versatility being of the utmost importance, Valarhash adds the new series…
Author: Marie Jones
The Greater Bay Area / GBA Youth Entrepreneurship (Employment) Camp, open for only three months, proudly announces success in helping overseas students find jobs and start their own businesses. More than 50 job seekers and entrepreneurs have joined the Camp for consultation and classes, while 16 entrepreneurial teams have settled in. The Camp held activities during this first quarter, talent, entrepreneurship and policy meetings, lectures on intellectual property (IP) and legal ownership, and courses to help prepare graduates and resident teams to solve issues they will encounter as entrepreneurs. At the same time, Hangcheng GBA Youth Entrepreneurship (Employment) Camp has…
The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical today accepted the MasterControl 2020 Innovation Excellence Award in a virtual ceremony. Avance Clinical made the announcement today at AusBiotech 2020 (28 – 30 October, 2020). https://www.ausbiotechnc.org/ Avance Clinical CEO Yvonne Lungershausen said the company was very pleased to be awarded such recognition by MasterControl, a leader in the clinical digital management technology. The MasterControl Clinical Excellence solution streamlines eTMF management and helps clients achieve real-time visibility into critical clinical processes across operational teams – all on one centralized platform. https://www.mastercontrol.com/clinical/ “The…
Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, congratulates client company Shasqi on the announcement of the first-ever application of click chemistry in humans, with the launch of the Company’s lead clinical candidate, SQ3370. Shasqi is the first Y Combinator-backed biotech company to reach clinical development. San Francisco-based Shasqi said in the announcement: First Patients Dosed in Phase 1 Clinical Study of SQ3370 for Advanced Solid Tumor Malignancies Shasqi is First Y-Combinator Biotech Company to Reach First-in-Human Clinical Studies Shasqi, a clinical-stage biotechnology company developing precision activated oncology therapeutics with its proprietary Click Activated Protodrugs Against…
Development of hydrophobic precious metal catalyst that improves hydrogen oxidation reaction and hydrogen infrastructure is evaluated TOKYO, Oct 29, 2020 – TANAKA Holdings Co., Ltd. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka) announced today that TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, has received the 2020 Technology Award from the Catalyst Manufacturers Association, Japan, (CMAJ). The award was in recognition of the company’s joint development of a hydrophobic precious metal catalyst in collaboration with the National Institutes for Quantum and Radiological Science…
From right to left: Group photo of Mr. Daniel Kwong, Chief Information and Innovation Officer from CITIC Telecom CPC, Mr. Joe Yau, CEO at OpenRice, and Mr. Taylor Lam, Senior Vice President of Product Development & Management at CITIC Telecom CPC. CITIC Telecom International CPC Limited (“CITIC Telecom CPC”), a wholly owned subsidiary of CITIC Telecom International Holdings Limited (SEHK:1883) together with the most popular and award-winning dining guide OpenRice today celebrate their business collaboration. Using innovative technology to build a reliable dining experience and one-stop merchant platform, in reaching new heights for Asia FoodTech Ecosystems, OpenRice has won three…
According to SCMP: According to the recently announced third quarter performance forecasts, all major listed breeding companies have recorded varying degrees of profit growth. Meanwhile, Huaan Securities believes the price of live pigs has stabilized and rebounded, and is expected to remain relatively high in 2020-2021. In terms of new IPOs, Sichuan Tianzow Breeding Technology Co., Ltd. (1248.HK), a newcomer in the industry, began its public offering period from October 29 to November 6 and has priced its shares at a price ranging between HK$26.00 to HK$38.80. The company plans to become listed publicly on the Hong Kong Main Board…
Raffles Financial Group Limited (CSE: RICH) (FSE: 4VO) (OTC: RAFFF) (“Raffles” or “the Company”) today announces its financial results for the fiscal year ended June 30, 2020, highlighted by revenue of $8,866,672 and adjusted comprehensive income before other items and income tax expenses of $12,220,573. All amounts expressed are in Singapore dollars. 2020 Financial Highlights: – Total Revenue of $8,866,672 (2019: $11,533,334) – Adjusted comprehensive income before other items and income tax expenses3 of $12,220,573 (2019: $10,750,652) – Cash Flow from operations of $7,044,654 (2019: $11,002,734) – The Company generated cash inflow from financing activities of $20,296,000 (2019: cash outflow…
Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs. The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies. Importantly, the AU/EU model allows biotechs to keep their data and trial management in Australia, and take advantage of the Australian cash rebate of up to 43.5% on clinical trial costs, throughout all study phases, across both regions.…
Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, has partnered with Endpoints News to produce an exceptional step-by-step webinar on how to run your trial in Australia, and why Agilex Biolabs is the leading biolabs partner. Watch here (no charge) https://tinyurl.com/yyzf6o44 Agilex Biolabs is known internationally for its continued investment in the latest technology, and for attracting some of the leading scientists from Australia and around the world. The webinar was launched as part of Agilex Biolabs’ presence at Bio Europe. Click here to meet Agilex Biolabs at Bio Europe via the partneringone tool. https://informaconnect.com/bio-europe-virtual/ Dr…